The United States government will pay Pfizer Inc nearly $2bn for 100 million additional doses of its COVID-19 vaccine to bolster its supply as the country grapples with a nationwide spike in infections.
The company will deliver at least 70 million doses by June 30 and the rest no later than July 31, Pfizer said on Wednesday, bringing the total number of doses to 200 million for a total price of about $4bn.
The new deal comes amid a jump in US coronavirus infections that added more than a million new cases in just six days, according to a Reuters tally.
More than 322,000 Americans have died and there have been at least 18.2 million reported cases in the US, according to numbers compiled by Johns Hopkins University of Medicine.
WASHINGTON The U.S. government is negotiating with Pfizer to acquire tens of millions of additional vaccine doses in exchange for helping the pharmaceutical giant gain better access to manufacturing supplies. A person with knowledge of the negotiations told The Associated Press on Tuesday that the deal is under discussion but has not been finalized. […]
By Cherranda Smith
Dec 23, 2020
On Wednesday (December 23) pharmaceutical giant Pfizer announced the federal government placed an order for an additional 100 million doses of their coronavirus vaccine.
The agreement calls for a total of 200 million doses to be supplied by Pfizer and BioNTech to the US. Deliveries of all of the doses are expected to be fulfilled by the end of July 2021.
“With these 100 million additional doses, the United States will be able to protect more individuals and hopefully end this devastating pandemic more quickly,” Pfizer CEO
Albert Bourla said in a statement. “We look forward to continuing our work with the US government and healthcare providers around the country.”
Pfizer to supply US with additional 100 million doses of vaccine Published December 23, 2020
FILE - In this Dec. 17, 2020 file photo, prepared COVID-19 Pfizer-BioNTech vaccine syringes are seen at Edward Hospital in Naperville, Ill. The U.S. government is negotiating with Pfizer to acquire tens millions of additional vaccine doses in exchange for helping the pharmaceutical giant gain better access to manufacturing supplies. (AP Photo/Nam Y. Huh, File)
Share on Facebook
Print article WASHINGTON Pfizer said Wednesday it will supply the U.S. government with an additional 100 million doses of its COVID-19 vaccine under a new agreement between the pharmaceutical giant and the Trump administration.
While people across New Jersey cheer the videos of the first hospital workers receiving COVID vaccines, a far greater challenge looms for the state in the weeks ahead. New Jersey is about to embark on the largest immunization program in its history, with limited resources and so far, at least insufficient funds.
Reaching the goal of inoculating 70% of New Jersey’s population 4.7 million people will require manpower and sites with room to do it, a massive expansion of data systems to schedule and track the two-dose vaccines, and a blitz of public information and advertising unlike anything seen before.
But public health departments at the state and local levels already are struggling to keep up with the demands of the pandemic. Underfunded for years, their hopes of expansion have dwindled along with tax revenues. Hospitals are grappling with a rising tide of coronavirus cases while their budgets falter because fewer patients seek elective surgeries and other types